| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |